The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-11

AUTHORS

William P. Parker, Philip L. Ho, Stephen A. Boorjian, Jonathan J. Melquist, Prabin Thapa, Jeffrey M. Holzbeierlein, Igor Frank, Ashish M. Kamat, Eugene K. Lee

ABSTRACT

PURPOSE: Patients without evidence of disease at radical cystectomy (RC) following neoadjuvant chemotherapy (NAC) have the greatest potential for survival in muscle-invasive bladder cancer. Historically, 15 % of such patients will experience disease recurrence and cancer-specific mortality. We sought to evaluate the effect of pre-treatment clinical factors on the risk of recurrence in patients who were ypT0N0 at RC. METHODS: We performed a multi-institutional review of patients treated with NAC + RC for muscle-invasive bladder cancer (≥cT2) without pathologic evidence of disease at surgery (ypT0N0). The association of pre-treatment clinicopathologic features with recurrence was evaluated using Cox proportional hazards. RESULTS: A total of 78 patients were identified with ypT0 disease at RC after NAC. Median postoperative follow-up was 32.4 months (IQR 16.8, 60.0), during which time 17 patients recurred at a median of 6.4 months after RC. Estimated 3-year recurrence-free survival (RFS) of this cohort was 74.8 %. In univariate analysis, cT4 disease (HR 3.12; p = 0.04) and time to RC (HR 1.17 for each month increase; p < 0.01) were associated with inferior RFS. CONCLUSION: Patients without evidence of disease at the time of RC are still at risk of recurrence and death from bladder cancer. Higher clinical stage and increased time to RC were associated with an increased risk of recurrence and subsequent death. These data highlight the importance of timely RC and the continued risk of recurrence in higher clinically staged patients-underscoring the need for close monitoring and patient counseling. More... »

PAGES

1561-1566

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00345-016-1801-y

DOI

http://dx.doi.org/10.1007/s00345-016-1801-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1028841531

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26943643


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Transitional Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cystectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Incidence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoadjuvant Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Urinary Bladder Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Mayo Clinic", 
          "id": "https://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Department of Urology, Mayo Clinic, 200 1st St SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Parker", 
        "givenName": "William P.", 
        "id": "sg:person.0647272377.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647272377.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard Unit 1373, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ho", 
        "givenName": "Philip L.", 
        "id": "sg:person.0757642475.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757642475.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mayo Clinic", 
          "id": "https://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Department of Urology, Mayo Clinic, 200 1st St SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boorjian", 
        "givenName": "Stephen A.", 
        "id": "sg:person.01252075004.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252075004.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard Unit 1373, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Melquist", 
        "givenName": "Jonathan J.", 
        "id": "sg:person.0705256306.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705256306.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mayo Clinic", 
          "id": "https://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Department of Urology, Mayo Clinic, 200 1st St SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thapa", 
        "givenName": "Prabin", 
        "id": "sg:person.0621722344.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621722344.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Kansas Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412016.0", 
          "name": [
            "Department of Urology, The University of Kansas Medical Center, 3901 Rainbow Blvd, MS 3016, 66160, Kansas City, KS, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Holzbeierlein", 
        "givenName": "Jeffrey M.", 
        "id": "sg:person.0621013747.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621013747.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mayo Clinic", 
          "id": "https://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Department of Urology, Mayo Clinic, 200 1st St SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Frank", 
        "givenName": "Igor", 
        "id": "sg:person.0715406560.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715406560.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of Texas MD Anderson Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard Unit 1373, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kamat", 
        "givenName": "Ashish M.", 
        "id": "sg:person.016172066457.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016172066457.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Kansas Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412016.0", 
          "name": [
            "Department of Urology, The University of Kansas Medical Center, 3901 Rainbow Blvd, MS 3016, 66160, Kansas City, KS, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Eugene K.", 
        "id": "sg:person.013340047737.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013340047737.80"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.juro.2011.06.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008247198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.eururo.2014.09.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009059234"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-410x.2011.10446.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010158464"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.urolonc.2009.12.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010923438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.eururo.2011.12.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011060050"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clgc.2014.01.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011358184"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.juro.2010.09.110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011724159"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa022148", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017518186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.eururo.2011.12.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019116907"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.eururo.2013.06.049", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021942255"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejso.2014.08.479", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022651935"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.juro.2013.10.142", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030613713"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.24052", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031579809"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-010-0985-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033481932", 
          "https://doi.org/10.1245/s10434-010-0985-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.eururo.2007.03.086", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036059601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.juro.2014.03.078", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040342360"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/caac.21208", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041182772"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.eururo.2005.04.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041745561"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0000000000000573", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042649655"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0000000000000573", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042649655"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00345-011-0817-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042876638", 
          "https://doi.org/10.1007/s00345-011-0817-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2014.01.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047784452"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-410x.2010.09628.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051888585"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4143/crt.2014.157", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072255895"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2013.0059", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078716412"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2013.0059", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078716412"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-11", 
    "datePublishedReg": "2016-11-01", 
    "description": "PURPOSE: Patients without evidence of disease at radical cystectomy (RC) following neoadjuvant chemotherapy (NAC) have the greatest potential for survival in muscle-invasive bladder cancer. Historically, 15\u00a0% of such patients will experience disease recurrence and cancer-specific mortality. We sought to evaluate the effect of pre-treatment clinical factors on the risk of recurrence in patients who were ypT0N0 at RC.\nMETHODS: We performed a multi-institutional review of patients treated with NAC\u00a0+\u00a0RC for muscle-invasive bladder cancer (\u2265cT2) without pathologic evidence of disease at surgery (ypT0N0). The association of pre-treatment clinicopathologic features with recurrence was evaluated using Cox proportional hazards.\nRESULTS: A total of 78 patients were identified with ypT0 disease at RC after NAC. Median postoperative follow-up was 32.4\u00a0months (IQR 16.8, 60.0), during which time 17 patients recurred at a median of 6.4\u00a0months after RC. Estimated 3-year recurrence-free survival (RFS) of this cohort was 74.8\u00a0%. In univariate analysis, cT4 disease (HR 3.12; p\u00a0=\u00a00.04) and time to RC (HR 1.17 for each month increase; p\u00a0<\u00a00.01) were associated with inferior RFS.\nCONCLUSION: Patients without evidence of disease at the time of RC are still at risk of recurrence and death from bladder cancer. Higher clinical stage and increased time to RC were associated with an increased risk of recurrence and subsequent death. These data highlight the importance of timely RC and the continued risk of recurrence in higher clinically staged patients-underscoring the need for close monitoring and patient counseling.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00345-016-1801-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094127", 
        "issn": [
          "0724-4983", 
          "1433-8726"
        ], 
        "name": "World Journal of Urology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "34"
      }
    ], 
    "name": "The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy", 
    "pagination": "1561-1566", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "8964b611683ff68b305c7a5a0a389c6c24a1d6e81ad8a6dffc9c26523cfaecf3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26943643"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8307716"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00345-016-1801-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1028841531"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00345-016-1801-y", 
      "https://app.dimensions.ai/details/publication/pub.1028841531"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000513.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00345-016-1801-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00345-016-1801-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00345-016-1801-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00345-016-1801-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00345-016-1801-y'


 

This table displays all metadata directly associated to this object as RDF triples.

281 TRIPLES      21 PREDICATES      72 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00345-016-1801-y schema:about N02120dcac0874c74a8fc7c2709cfedff
2 N0a66dc15ba714518b1eab8b51d569723
3 N0d6374af29b54ade9d8f7ca112b8520d
4 N393beefb8c914be2b63d5c935e1d8485
5 N4cd0b616fdee47c49984a4549f23ba4e
6 N4ddf51143a1e4c55939f6388647bbe31
7 N673378af217048a48e7490f84167a435
8 N779159acdea74c5dad810280a7c560cb
9 N80d1a0a46fed448b88de93c4016301cd
10 N836422036b9b48a0a33089183aa7e899
11 N8eb00a29827f42b98fd31f7bcaa9363e
12 Na882e4d13b974691aa5da231b24ff641
13 Na976118ee72949e2b7658bfe29ac8732
14 Nb245a694ab904d1680cf8c8794ee1d5e
15 Nb6de645c6b1741aba48859eed0e5e50f
16 Nbc8e7820465341a89a805e41a6d5b0ff
17 Nde18959bd24c4faaad55eaf24fabac29
18 Ne8d84fe4312e4546914235abc9aaeab9
19 Nf7766ad329734edd8ca80c7b7e9fc2da
20 anzsrc-for:11
21 anzsrc-for:1112
22 schema:author Nb0340cab811e4d8e8d7f962408056ede
23 schema:citation sg:pub.10.1007/s00345-011-0817-6
24 sg:pub.10.1245/s10434-010-0985-4
25 https://doi.org/10.1002/cncr.24052
26 https://doi.org/10.1016/j.clgc.2014.01.005
27 https://doi.org/10.1016/j.ejso.2014.08.479
28 https://doi.org/10.1016/j.eururo.2005.04.006
29 https://doi.org/10.1016/j.eururo.2007.03.086
30 https://doi.org/10.1016/j.eururo.2011.12.009
31 https://doi.org/10.1016/j.eururo.2011.12.010
32 https://doi.org/10.1016/j.eururo.2013.06.049
33 https://doi.org/10.1016/j.eururo.2014.09.007
34 https://doi.org/10.1016/j.ijrobp.2014.01.001
35 https://doi.org/10.1016/j.juro.2010.09.110
36 https://doi.org/10.1016/j.juro.2011.06.004
37 https://doi.org/10.1016/j.juro.2013.10.142
38 https://doi.org/10.1016/j.juro.2014.03.078
39 https://doi.org/10.1016/j.urolonc.2009.12.020
40 https://doi.org/10.1056/nejmoa022148
41 https://doi.org/10.1097/rlu.0000000000000573
42 https://doi.org/10.1111/j.1464-410x.2010.09628.x
43 https://doi.org/10.1111/j.1464-410x.2011.10446.x
44 https://doi.org/10.3322/caac.21208
45 https://doi.org/10.4143/crt.2014.157
46 https://doi.org/10.6004/jnccn.2013.0059
47 schema:datePublished 2016-11
48 schema:datePublishedReg 2016-11-01
49 schema:description PURPOSE: Patients without evidence of disease at radical cystectomy (RC) following neoadjuvant chemotherapy (NAC) have the greatest potential for survival in muscle-invasive bladder cancer. Historically, 15 % of such patients will experience disease recurrence and cancer-specific mortality. We sought to evaluate the effect of pre-treatment clinical factors on the risk of recurrence in patients who were ypT0N0 at RC. METHODS: We performed a multi-institutional review of patients treated with NAC + RC for muscle-invasive bladder cancer (≥cT2) without pathologic evidence of disease at surgery (ypT0N0). The association of pre-treatment clinicopathologic features with recurrence was evaluated using Cox proportional hazards. RESULTS: A total of 78 patients were identified with ypT0 disease at RC after NAC. Median postoperative follow-up was 32.4 months (IQR 16.8, 60.0), during which time 17 patients recurred at a median of 6.4 months after RC. Estimated 3-year recurrence-free survival (RFS) of this cohort was 74.8 %. In univariate analysis, cT4 disease (HR 3.12; p = 0.04) and time to RC (HR 1.17 for each month increase; p < 0.01) were associated with inferior RFS. CONCLUSION: Patients without evidence of disease at the time of RC are still at risk of recurrence and death from bladder cancer. Higher clinical stage and increased time to RC were associated with an increased risk of recurrence and subsequent death. These data highlight the importance of timely RC and the continued risk of recurrence in higher clinically staged patients-underscoring the need for close monitoring and patient counseling.
50 schema:genre research_article
51 schema:inLanguage en
52 schema:isAccessibleForFree false
53 schema:isPartOf Ne123fe699dff4e9a9ac7d6c968ca9ed9
54 Ne1cd4ff27559485e9361e16b2265b98f
55 sg:journal.1094127
56 schema:name The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy
57 schema:pagination 1561-1566
58 schema:productId N098dffe1b08b439490a84eb02513a09c
59 N21084ab9d8074010b9434206f5b6072e
60 Nb7d387a3c91545cbbf76286b13c34f1a
61 Nbda38d2ac4dc47afaf6bffb0a4e99235
62 Nd3f852eccbd143959dee511b39e090e9
63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028841531
64 https://doi.org/10.1007/s00345-016-1801-y
65 schema:sdDatePublished 2019-04-10T17:32
66 schema:sdLicense https://scigraph.springernature.com/explorer/license/
67 schema:sdPublisher Nd17bd85960204cdbb13e9473d12f2cea
68 schema:url http://link.springer.com/10.1007%2Fs00345-016-1801-y
69 sgo:license sg:explorer/license/
70 sgo:sdDataset articles
71 rdf:type schema:ScholarlyArticle
72 N02120dcac0874c74a8fc7c2709cfedff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Prognosis
74 rdf:type schema:DefinedTerm
75 N07daf0f8de854ba38c11a360eddce409 rdf:first sg:person.0621013747.42
76 rdf:rest Nfde59e89cc3846f791d02dcddceed802
77 N098dffe1b08b439490a84eb02513a09c schema:name pubmed_id
78 schema:value 26943643
79 rdf:type schema:PropertyValue
80 N0a66dc15ba714518b1eab8b51d569723 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Aged
82 rdf:type schema:DefinedTerm
83 N0d6374af29b54ade9d8f7ca112b8520d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Retrospective Studies
85 rdf:type schema:DefinedTerm
86 N21084ab9d8074010b9434206f5b6072e schema:name doi
87 schema:value 10.1007/s00345-016-1801-y
88 rdf:type schema:PropertyValue
89 N2ef5e2c6b9624b87921e4d4d858df0ad rdf:first sg:person.0757642475.43
90 rdf:rest N7b532d16de2142e0a01704cc52c539d4
91 N393beefb8c914be2b63d5c935e1d8485 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Female
93 rdf:type schema:DefinedTerm
94 N4a134a459817434a90e743eb301262ca rdf:first sg:person.013340047737.80
95 rdf:rest rdf:nil
96 N4cd0b616fdee47c49984a4549f23ba4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Urinary Bladder Neoplasms
98 rdf:type schema:DefinedTerm
99 N4ddf51143a1e4c55939f6388647bbe31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Follow-Up Studies
101 rdf:type schema:DefinedTerm
102 N65d072188678496f882955da7dfe62b4 rdf:first sg:person.016172066457.96
103 rdf:rest N4a134a459817434a90e743eb301262ca
104 N673378af217048a48e7490f84167a435 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name United States
106 rdf:type schema:DefinedTerm
107 N779159acdea74c5dad810280a7c560cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Cystectomy
109 rdf:type schema:DefinedTerm
110 N7b532d16de2142e0a01704cc52c539d4 rdf:first sg:person.01252075004.00
111 rdf:rest Nf5208d5ae04f43cbad2432ae3de8c6ec
112 N80d1a0a46fed448b88de93c4016301cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Neoadjuvant Therapy
114 rdf:type schema:DefinedTerm
115 N836422036b9b48a0a33089183aa7e899 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Incidence
117 rdf:type schema:DefinedTerm
118 N8eb00a29827f42b98fd31f7bcaa9363e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Antineoplastic Agents
120 rdf:type schema:DefinedTerm
121 Na882e4d13b974691aa5da231b24ff641 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Carcinoma, Transitional Cell
123 rdf:type schema:DefinedTerm
124 Na976118ee72949e2b7658bfe29ac8732 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Male
126 rdf:type schema:DefinedTerm
127 Naca41eafa60548688cbf24dd17d943ea rdf:first sg:person.0621722344.38
128 rdf:rest N07daf0f8de854ba38c11a360eddce409
129 Nb0340cab811e4d8e8d7f962408056ede rdf:first sg:person.0647272377.56
130 rdf:rest N2ef5e2c6b9624b87921e4d4d858df0ad
131 Nb245a694ab904d1680cf8c8794ee1d5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Humans
133 rdf:type schema:DefinedTerm
134 Nb6de645c6b1741aba48859eed0e5e50f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Middle Aged
136 rdf:type schema:DefinedTerm
137 Nb7d387a3c91545cbbf76286b13c34f1a schema:name nlm_unique_id
138 schema:value 8307716
139 rdf:type schema:PropertyValue
140 Nbc8e7820465341a89a805e41a6d5b0ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Neoplasm Staging
142 rdf:type schema:DefinedTerm
143 Nbda38d2ac4dc47afaf6bffb0a4e99235 schema:name readcube_id
144 schema:value 8964b611683ff68b305c7a5a0a389c6c24a1d6e81ad8a6dffc9c26523cfaecf3
145 rdf:type schema:PropertyValue
146 Nd17bd85960204cdbb13e9473d12f2cea schema:name Springer Nature - SN SciGraph project
147 rdf:type schema:Organization
148 Nd3f852eccbd143959dee511b39e090e9 schema:name dimensions_id
149 schema:value pub.1028841531
150 rdf:type schema:PropertyValue
151 Nde18959bd24c4faaad55eaf24fabac29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Disease-Free Survival
153 rdf:type schema:DefinedTerm
154 Ne123fe699dff4e9a9ac7d6c968ca9ed9 schema:volumeNumber 34
155 rdf:type schema:PublicationVolume
156 Ne1cd4ff27559485e9361e16b2265b98f schema:issueNumber 11
157 rdf:type schema:PublicationIssue
158 Ne8d84fe4312e4546914235abc9aaeab9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Neoplasm Recurrence, Local
160 rdf:type schema:DefinedTerm
161 Nf5208d5ae04f43cbad2432ae3de8c6ec rdf:first sg:person.0705256306.50
162 rdf:rest Naca41eafa60548688cbf24dd17d943ea
163 Nf7766ad329734edd8ca80c7b7e9fc2da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Survival Rate
165 rdf:type schema:DefinedTerm
166 Nfde59e89cc3846f791d02dcddceed802 rdf:first sg:person.0715406560.01
167 rdf:rest N65d072188678496f882955da7dfe62b4
168 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
169 schema:name Medical and Health Sciences
170 rdf:type schema:DefinedTerm
171 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
172 schema:name Oncology and Carcinogenesis
173 rdf:type schema:DefinedTerm
174 sg:journal.1094127 schema:issn 0724-4983
175 1433-8726
176 schema:name World Journal of Urology
177 rdf:type schema:Periodical
178 sg:person.01252075004.00 schema:affiliation https://www.grid.ac/institutes/grid.66875.3a
179 schema:familyName Boorjian
180 schema:givenName Stephen A.
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252075004.00
182 rdf:type schema:Person
183 sg:person.013340047737.80 schema:affiliation https://www.grid.ac/institutes/grid.412016.0
184 schema:familyName Lee
185 schema:givenName Eugene K.
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013340047737.80
187 rdf:type schema:Person
188 sg:person.016172066457.96 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
189 schema:familyName Kamat
190 schema:givenName Ashish M.
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016172066457.96
192 rdf:type schema:Person
193 sg:person.0621013747.42 schema:affiliation https://www.grid.ac/institutes/grid.412016.0
194 schema:familyName Holzbeierlein
195 schema:givenName Jeffrey M.
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621013747.42
197 rdf:type schema:Person
198 sg:person.0621722344.38 schema:affiliation https://www.grid.ac/institutes/grid.66875.3a
199 schema:familyName Thapa
200 schema:givenName Prabin
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621722344.38
202 rdf:type schema:Person
203 sg:person.0647272377.56 schema:affiliation https://www.grid.ac/institutes/grid.66875.3a
204 schema:familyName Parker
205 schema:givenName William P.
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647272377.56
207 rdf:type schema:Person
208 sg:person.0705256306.50 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
209 schema:familyName Melquist
210 schema:givenName Jonathan J.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705256306.50
212 rdf:type schema:Person
213 sg:person.0715406560.01 schema:affiliation https://www.grid.ac/institutes/grid.66875.3a
214 schema:familyName Frank
215 schema:givenName Igor
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715406560.01
217 rdf:type schema:Person
218 sg:person.0757642475.43 schema:affiliation https://www.grid.ac/institutes/grid.240145.6
219 schema:familyName Ho
220 schema:givenName Philip L.
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757642475.43
222 rdf:type schema:Person
223 sg:pub.10.1007/s00345-011-0817-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042876638
224 https://doi.org/10.1007/s00345-011-0817-6
225 rdf:type schema:CreativeWork
226 sg:pub.10.1245/s10434-010-0985-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033481932
227 https://doi.org/10.1245/s10434-010-0985-4
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1002/cncr.24052 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031579809
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1016/j.clgc.2014.01.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011358184
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1016/j.ejso.2014.08.479 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022651935
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1016/j.eururo.2005.04.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041745561
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1016/j.eururo.2007.03.086 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036059601
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1016/j.eururo.2011.12.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011060050
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1016/j.eururo.2011.12.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019116907
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1016/j.eururo.2013.06.049 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021942255
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1016/j.eururo.2014.09.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009059234
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1016/j.ijrobp.2014.01.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047784452
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1016/j.juro.2010.09.110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011724159
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1016/j.juro.2011.06.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008247198
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1016/j.juro.2013.10.142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030613713
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1016/j.juro.2014.03.078 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040342360
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1016/j.urolonc.2009.12.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010923438
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1056/nejmoa022148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017518186
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1097/rlu.0000000000000573 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042649655
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1111/j.1464-410x.2010.09628.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1051888585
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1111/j.1464-410x.2011.10446.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010158464
266 rdf:type schema:CreativeWork
267 https://doi.org/10.3322/caac.21208 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041182772
268 rdf:type schema:CreativeWork
269 https://doi.org/10.4143/crt.2014.157 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072255895
270 rdf:type schema:CreativeWork
271 https://doi.org/10.6004/jnccn.2013.0059 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078716412
272 rdf:type schema:CreativeWork
273 https://www.grid.ac/institutes/grid.240145.6 schema:alternateName The University of Texas MD Anderson Cancer Center
274 schema:name Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard Unit 1373, 77030, Houston, TX, USA
275 rdf:type schema:Organization
276 https://www.grid.ac/institutes/grid.412016.0 schema:alternateName University of Kansas Medical Center
277 schema:name Department of Urology, The University of Kansas Medical Center, 3901 Rainbow Blvd, MS 3016, 66160, Kansas City, KS, USA
278 rdf:type schema:Organization
279 https://www.grid.ac/institutes/grid.66875.3a schema:alternateName Mayo Clinic
280 schema:name Department of Urology, Mayo Clinic, 200 1st St SW, 55905, Rochester, MN, USA
281 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...